Search

Search Results

• Response to Interferon-Free Direct Antivirals (DAAS) Treatment in HCV-Related Subcutaneous Lipoma-Like Marginal Zone B-Cell Lymphoma

  Maria Lucia De Luca, Laura Lombardi, Germana Tartaglia, Francesca Fazio, Alessio Di Prima, Laura Cesini, Alessandra Serrao, Martina Canichella, Alessandro Pulsoni

  e2019053

  2019-08-29

  https://doi.org/10.4084/mjhid.2019.053

  1140

  PDF: 833

  HTML: 190

• Life-threatening autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura: successful seletive splenic artery embolization

  matteo molica, Fulvio Massaro, Giorgia Annechini, Erminia Baldacci, Gianna maria D'elia, Riccardo Rosati, Silvia maria trisolini, Paola Volpicelli, Robin Foà, Saveria Capria

  e2016020

  2016-04-10

  https://doi.org/10.4084/mjhid.2016.020

  3447

  PDF: 991

  HTML: 2333

• IN UTERO HAEMATOPOIETIC STEM CELL TRANSPLANTATION (IUHSCT)

  Maria Concetta Renda, Aurelio Maggio

  e2009031

  2009-12-29

  1055

  PDF: 455

  HTML: 881

• TYPICAL AND ATYPICAL PRESENTATION OF COVID-19 INFECTION IN CHILDREN IN THE TOP OF PANDEMIC IN MINIA GOVERNORATE (TWO CENTER EXPERIENCE)

  Madeha Abdalla Sayed, Mohamed Abdelhakeem

  e2022002

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.002

  1583

  PDF: 580

  HTML: 257

• TREATMENT PATTERNS IN PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKAEMIA IN ROUTINE CLINICAL PRACTICE: THE SIMPLICITY ITALIAN POPULATION

  Elisabetta Abruzzese

  e2019025

  2019-04-26

  https://doi.org/10.4084/mjhid.2019.025

  1963

  PDF: 1065

  HTML: 173

• NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?

  Alessandro Corso, Silvia Mangiacavalli

  e2017053

  2017-08-18

  https://doi.org/10.4084/mjhid.2017.053

  3246

  PDF: 1709

  HTML: 1084

• IMMUNITY TO INFECTIONS AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

  Franco Aversa, Lucia Prezioso, Ilenia Manfra, Federica Galaverna, Angelica Spolzino, Alessandro Monti

  e2016057

  2016-10-25

  https://doi.org/10.4084/mjhid.2016.057

  4322

  PDF: 1101

  HTML: 1418

• THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA

  Davide Rossi, Marco Fangazio, Gianluca Gaidano

  e2012076

  2012-11-13

  https://doi.org/10.4084/mjhid.2012.076

  2234

  PDF: 880

  HTML: 2000

  Fig 1 Rossi: 176

• BASELINE THROMBIN GENERATION TEST DOES NOT PREDICT THROMBOTIC EVENTS IN ACUTE LEUKEMIA: A MONOCENTRIC PROSPECTIVE STUDY

  Mario Biglietto, Rosaria Mormile, Maria Laura Bisegna, Alessandro Laganà, Anna Laura Faccini, Andrea Papa, Erminia Baldacci, Cristina Santoro, Maria Stefania De Propris, Antonio Chistolini

  e2025076

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.076

  393

  PDF: 183

  Html: 45

• HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation

  Anna Maria Testi

  e2022038

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.038

  1115

  PDF: 763

  HTML: 206

• LIVER IRON CONTENT (LIC) IN ADULTS WITH NON-TRANSFUSION DEPENDENT SICKLE CELL DISEASE (NT-SCD). CORRELATION WITH SERUM FERRITIN AND LIVER ENZYMES CONCENTRATIONS

  Vincenzo De Sanctis

  e2017037

  2017-06-20

  https://doi.org/10.4084/mjhid.2017.037

  3823

  PDF: 960

  HTML: 1145

• HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA

  Giuseppe Avvisati

  e2011064

  2011-12-19

  https://doi.org/10.4084/mjhid.2011.064

  13255

  PDF: 966

  HTML: 7290

• Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA

  Michele Puppi, Ilaria Sacchetti, Katia Mancuso, Paola Tacchetti, Lucia Pantani, ilaria Rizzello, Miriam Iezza, Marco Talarico, Enrica Manzato, Simone Masci, Roberta Restuccia, Simona Barbato, Silvia Armuzzi, Barbara Taurisano, Ilaria Vigliotta, Elena Zamagni

  e2025045

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.045

  1566

  PDF: 1203

  HTML: 188

• Impressive continuous complete response after mogamulizumab in a heavily pre-treated Sézary syndrome patient

  Pier Luigi Zinzani, Ginevra Lolli, Beatrice Casadei, Lisa Argnani, Laura Nanni, Michele Cavo

  e2020040

  2020-06-28

  https://doi.org/10.4084/mjhid.2020.040

  1054

  PDF: 678

  HTML: 198

• LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE

  Massimo Breccia, Corrado Girmenia, Roberto Latagliata, Giuseppina Loglisci, Michelina Santopietro, Vincenzo Federico, Luigi Petrucci, Alessandra Serrao, Adriano Salaroli, Giuliana Alimena

  e2011021

  2011-05-16

  https://doi.org/10.4084/mjhid.2011.021

  1618

  PDF: 796

  HTML: 858

  jdoe, table 2 infections CML .doc: 194

  jdoe, table 1 infections CML .doc: 181

• EBV AND HIV-RELATED LYMPHOMA

  Michele Bibas, Andrea Antinori

  e2009032

  2009-12-29

  https://doi.org/10.4084/mjhid.2009.032

  1547

  PDF: 630

  HTML: 6811

• CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment

  Ugo Testa, Elvira Pelosi, Dr. Germana Castelli

  e2024077

  2024-10-31

  https://doi.org/10.4084/MJHID.2024.077

  1711

  PDF: 833

  HTML: 144

• CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma

  Ugo Testa, Francesco D'Alò, Elvira Pelosi, Germana Castelli, Giuseppe Leone

  e2024012

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.012

  2261

  PDF: 1816

  HTML: 143

• DIFFERENCES BETWEEN PEDIATRIC PULMONARY AND EXTRA-PULMONARY TUBERCULOSIS: A WARNING SIGN FOR THE FUTURE

  Ilker Devrim, Hüseyin Aktürk, Nuri Bayram, Hurşit Apa, Şener Tulumoğlu, Fatma Devrim, Ttulin Erdem, Gamze Gulfidan, Yüce Ayhan, Demet Can, Hüdaver Alper

  e2014058

  2014-08-28

  https://doi.org/10.4084/mjhid.2014.058

  2565

  PDF: 1341

  HTML: 4068

• NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES

  Francesco D'Alò, Mariangela Greco, Marianna Criscuolo, Maria Teresa Voso

  e2010021

  2010-08-11

  https://doi.org/10.4084/mjhid.2010.021

  1964

  PDF: 744

  HTML: 694

• OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES

  Jon Salmanton-Garcia, Francesco Marchesi, Oliver A. Cornely, Jannik Stemler, Pierantonio Menna

  2026-02-28

  https://doi.org/10.4084/MJHID.2026.022

  1024

  PDF: 1197

  Suppl. Files: 146

  HTML: 69

• SEROLOGICAL AND MOLECULAR DETECTION OF RICKETTSIA SPP STEMMING FROM HEMATOPHAGOUS VECTORS IN PATIENTS WITH MENINGEAL SYNDROME IN NORTHERN ALGERIA RICKETTSIA SPP IN PATIENTS WITH MENINGEAL SYNDROME

  HICHEM GHAOUI, IBRAHIM Nasir ADAM, BASHER Nosiba, TAKFARINAS IDRES, SORAYA TEMIM, ASMA SAAD-DJABALLAH , IDIR BITAM, NASSIMA ACHOUR

  e2025046

  2025-06-06

  https://doi.org/10.4084/MJHID.2025.046

  784

  PDF: 732

  HTML: 66

• PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis

  Fiorina Giona

  e2021069

  2021-10-29

  https://doi.org/10.4084/MJHID.2021.069

  1823

  HTML: 1442

  PDF: 1078

• NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa

  Alessandro Matte, Filippo Mazzi, Enrica Federti, Oliviero Olivieri, Lucia De Franceschi

  e2019002

  2019-01-01

  https://doi.org/10.4084/mjhid.2019.002

  6807

  PDF: 3643

  HTML: 753

• ASSESSMENT OF DIAGNOSTIC TECHNIQUES OF URINARY TUBERCULOSIS

  Khaled Ismail Ghaleb, Magdy Mohamed afifi, Mohamed Mohamed El Gohary

  e2013034

  2013-06-03

  https://doi.org/10.4084/mjhid.2013.034

  2004

  PDF: 775

  HTML: 2324

  Untitled: 210

• MOLECULAR CHARACTERIZATION OF VANCOMYCIN, MUPIROCIN AND ANTISEPTIC RESISTANT STAPHYLOCOCCUS AUREUS STRAINS.

  Mahtab Hadadi, Hamid Heidari, Hadi Sedigh Ebrahim-Saraie, Mohammad Motamedifar

  e2018053

  2018-09-01

  https://doi.org/10.4084/mjhid.2018.053

  1842

  PDF: 956

  HTML: 164

• MOLECULAR HETEROGENEITY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN BURKINA FASO: G-6-PD BETICA SELMA AND SANTAMARIA IN PEOPLE WITH SYMPTOMATIC MALARIA IN OUAGADOUGOU

  Abdoul Karim OUATTARA, Pouiré YAMEOGO, Birama DIARRA, Dorcas OBIRI-YEBOAH, Albert Theophane YONLI, Tegwindé Rebeca COMPAORE, Serge Théophile SOUBEIGA, Florencia Wenkuuni DJIGMA, Jacques Simpore

  e2016029

  2016-06-15

  https://doi.org/10.4084/mjhid.2016.029

  4151

  PDF: 989

  HTML: 1295

• PHYSICIAN’S ATTITUDE TOWARDS TREATMENT OF OLDER PATIENTS AND THE CHOICE OF THERAPY

  Felicetto Ferrara

  e2013025

  2013-04-10

  https://doi.org/10.4084/mjhid.2013.025

  2350

  PDF: 781

  HTML: 1848

• Progression from Carbapenem-Resistant Enterobacterales Colonization to Bloodstream Infection in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Cohort Study

  Candida Diaz, Daniela Rodriguez-Feria, Javier Garzon, Oscar Muñoz

  e2026041

  2026-04-30

  https://doi.org/10.4084/MJHID.2026.041

  153

  PDF: 153

  HTML: 20

• COULD PLASMA GLUCOSE (PG) INCREMENT (PG %) EXPAND THE CLINICAL WEIGHT OF OGTT? PRELIMINARY FINDINGS IN 19 TDT PATIENTS (Β-TDT) WITH NORMAL GLUCOSE TOLERANCE Plasma glucose (PG) increment (PG %) and pancretic β-cell dysfunction in thalassemia

  Vincenzo De Sanctis, Ashraf Soliman, Shahina Daar, Ploutarchos Tzoulis, Christos Kattamis

  e2025050

  2025-06-29

  https://doi.org/10.4084/MJHID.2025.050

  707

  PDF: 490

  HTML: 41

• Worldwide distribution of prekallikrein (PK) deficiency: the defect seems mainly concentrated in West African countries and in the United States Worldwide distribution of PK deficiency:

  Antonio Girolami, Silvia Ferrari

  e2021014

  2021-01-01

  https://doi.org/10.4084/mjhid.2021.014

  1047

  PDF: 260

  HTML: 151

• SERO PREVALENCE OF TOXARA CANIS IN THE CITY OF CATANIA, ITALY.

  Alessandra Nicoletti, Calogero Edoardo Cicero, Antonia Mantella, Loretta Giuliano, Cristina Rascunà, Vincenza Paradisi, Alessandro Bartoloni, Mario Zappia, Vito Sofia

  e2019031

  2019-04-27

  https://doi.org/10.4084/mjhid.2019.031

  1363

  PDF: 945

  HTML: 219

• TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi

  e2023038

  2023-06-29

  https://doi.org/10.4084/MJHID.2023.038

  2119

  PDF: 1690

  HTML: 376

• PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES

  Stefano Lancellotti, Maria Basso, Raimondo De Cristofaro

  e2013058

  2013-09-01

  https://doi.org/10.4084/mjhid.2013.058

  3460

  PDF: 1163

  HTML: 24020

• EBV IN HODGKIN LYMPHOMA

  Giuseppina Massini, Doerte Siemer, Stefan Hohaus

  e2009013

  https://doi.org/10.4084/mjhid.2009.013

  1649

  PDF: 599

  HTML: 13940

• CUPROPTOSIS: A REVIEW ON MECHANISMS, ROLE IN SOLID AND HEMATOLOGICAL TUMORS, AND ASSOCIATION WITH VIRAL INFECTIONS

  MAURIZIO MARTINI, Pietro Tralongo, Mariagiovanna Ballato, Vincenzo Fiorentino, Walter Giordano, Valeria zuccalà, Cristina Pizzimenti, Arianna Bakacs, Antonio Ieni, Giovanni Tuccari, Guido Fadda, Luigi Maria Larocca

  e2025052

  2025-06-29

  https://doi.org/10.4084/MJHID.2025.052

  1691

  PDF: 973

  HTML: 184

• EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?

  Pellegrino Musto, Dr. Nicola Sgherza

  e2024073

  2024-08-31

  https://doi.org/10.4084/MJHID.2024.073

  1515

  PDF: 800

  HTML: 154

• Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS

  Yasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda

  e2025026

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.026

  1898

  PDF: 1631

  HTML: 123

• BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN

  Maria Teresa Voso, Giulia Falconi, Dr. Fabiani

  e2023055

  2023-08-29

  https://doi.org/10.4084/MJHID.2023.055

  1780

  PDF: 965

  HTML: 141

• NOVEL DRUGS IN FOLLICULAR LYMPHOMA

  Giuseppe Rossi, Antonella Anastasia

  e2016061

  2016-11-01

  https://doi.org/10.4084/mjhid.2016.061

  4308

  PDF: 1487

  HTML: 1547

  Untitled: 225

• THALASSEMIA AND VENOUS THROMBOEMBOLISM

  Julien Succar, Khaled M. Musallam, Ali T Taher

  e2011025

  2011-05-25

  https://doi.org/10.4084/mjhid.2011.025

  2919

  PDF: 1019

  HTML: 4583

• APLASTIC ANEMIA AND VIRAL HEPATITIS

  Laura Cudillo

  e2009026

  https://doi.org/10.4084/mjhid.2009.026

  1255

  PDF: 527

  HTML: 23042

• SARS-CoV-2 Transmission and Outcome in Neuro-rehabilitation patients hospitalized at Neuroscience Hospital in Italy SARS CoV 2 in severe neurological patients

  Francesco Di Gennaro

  e2020063

  2020-08-29

  https://doi.org/10.4084/mjhid.2020.063

  1066

  PDF: 714

  HTML: 212

• BENDAMUSTINE AND RITUXIMAB AS FIRST LINE TREATMENT IN SPLENIC MARGINAL ZONE LYMPHOMAS of ELDERLY PATIENTS.

  Roberto Castelli

  e2016030

  2016-07-01

  https://doi.org/10.4084/mjhid.2016.030

  4350

  PDF: 980

  HTML: 1678

• TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo

  e2025039

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.039

  2189

  PDF: 1483

  HTML: 264

• UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)

  José Luis Piñana, Estela Giménez, Lourdes Vázquez, María Ángeles Marcos, Manuel Guerreiro, Rafael Duarte, Ariadna Pérez, Carlos de Miguel, Ildefonso Espigado, Marta González-Vicent, María Suarez-Lledó, Irene García-Cadenas, Rodrigo Martino, Angel Cedillo, Monserrat Rovira, Rafael de la Cámara, David Navarro, Carlos Solano

  e2024065

  2024-08-31

  https://doi.org/10.4084/MJHID.2024.065

  3903

  Suppl. Files: 1107

  PDF: 1061

  Html: 174

• THE GROWING ROLE OF THE BH3 MIMETIC DRUG VENETOCLAX IN THE THERAPY OF ACUTE MYELOID LEUKEMIA

  Elvira Pelosi, Dr. Germana Castelli, Ugo Testa

  e2022080

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.080

  1474

  PDF: 1143

  HTML: 272

• PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS

  Mario Sabatelli, Luca Laurenti, Marco Luigetti

  e2018057

  2018-09-01

  https://doi.org/10.4084/mjhid.2018.057

  1752

  PDF: 876

  HTML: 373

  Fig1: 231

  Fig.2: 251

  Fig. 3: 181

  Fig. 5: 195

  Fig. 4: 223

• BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL

  Ugo Testa, Elvira Pelosi, Germana Castelli, Patrizia Chiusolo

  e2024070

  2024-08-31

  https://doi.org/10.4084/MJHID.2024.070

  1621

  PDF: 1092

  HTML: 117

• Parvovirus B19 infection in a patient with common variable immunodeficiency Parvovirus B19 infection in a patient with common variable immunodeficiency

  Magda Zanelli, Loredana Reggiani, Francesca Sanguedolce, Maurizio Zizzo, Giovanni Martino, Angelo Genua, Stefano Ascani

  e2021026

  2021-02-26

  https://doi.org/10.4084/mjhid.2021.026

  1068

  PDF: 379

  HTML: 281